Modern approaches in caries treatment involve lesion management without tissue removal. Regenerative medicine focuses on replacing damaged tissues with biologically similar tissues. This article discusses the scientific evidence and clinical results for self-assembling peptides in modern caries management. The biomimetic remineralization promoted by self-assembling peptide P11-4 has been proven in vitro as an effective therapy for initial caries. P11-4 was rationally designed to promote formation of hydroxyapatite on its surface. The formulation was optimized to ensure the ability of monomeric P11-4 to penetrate past the subsurface lesions and assembly into a biomatrix within. Furthermore, P11-4 has shown that it assembles into fibers within carious lesions, and promotes the remineralization thereof. In a recent clinical study, the safety and efficacy of P11-4 in treatment of initial caries were evaluated. The additional effect of the application of P11-4 (Curodont Repair) was compared to the application of fluoride varnish (Duraphat) alone in active occlusal initial caries lesions on erupting permanent molars. In the 3-and 6-month recalls, the test group showed, both in the laser fluorescence readings and in the clinical assessment of the caries stage and activity, significantly superior lesion regression compared to the control group. No adverse events, medical complications, or allergic reactions related to the treatments were reported. Clinical applicability of treatment was regarded as satisfactory. Patients were happy to receive noninvasive caries treatments. In conclusion, biomimetic mineralization facilitated by P11-4 in combination with fluoride may present a simple, safe, and effective noninvasive treatment for early carious lesions.
Introduction
Contemporarily, dental caries are defined as pathophysiological processes in the dental biofilm that cause an imbalance in the demineralization-remineralization equilibrium, leading to the net loss of tooth minerals progressing to a cavity (Steinberg 2007) . Better understanding of the underlying etiological mechanisms of the disease has contributed to the development of more therapeutic approaches in caries management for both primary and permanent teeth.
Cavitated carious lesions at the macroscopic level have been traditionally "treated" with surgical methods involving complete caries removal and sealing. There is growing evidence and international consensus (Innes et al. 2016; Schwendicke et al. 2016) , however, supporting the use of less invasive interventions focusing on lesion control rather than on removal of affected tissue. Therefore, the use of restorative treatment is limited primarily to cavitated "noncleansable" carious lesions, or to restore the function, form, and aesthetics of affected teeth (Innes and Schwendicke 2017) . Thus, the traditional treatment of cavitated lesions by drilling and filling, which merely constitutes replacing the damaged tissue by a foreign material, temporarily masking the process, and starting the restoration cycle, has been challenged by less invasive and more biological approaches such as remineralization and regeneration of the biological tissue (Kidd 2004; Schwendicke et al. 2016) .
For "early" carious lesions, current evidence suggests the use of noninvasive and nonrestorative methods (Splieth et al. 2010; Tellez et al. 2013; Dorri et al. 2015) , like sealing carious lesions (sealants and resin infiltration), and remineralization procedures mainly with fluorides (varnishes, gels, and toothpaste; Marinho et al. 2003; Marinho et al. 2013) or using CPP-ACP (casein phosphopeptide amorphous calcium phosphate) vehicles alone or in combination with fluoride interventions (Gupta et al. 2016) . Remineralization focuses on inactivating the lesion, shifting the equilibrium toward remineralization by reducing the solubility of the dental tissue or increasing the surface area for mineral redeposition (Weatherell et al. 1977; Reynolds 2005 ). In addition, biofilm removal and diet control support natural remineralization of the carious lesions via Ca from saliva (de Almeida Pdel et al. 2008) . However, saliva's regenerative potential is limited to enamel that is marginally affected by caries (Dowd 1999 ).
An alternative approach to the current strategies for managing noncavitated carious lesions at the macroscopic level is the recently introduced self-assembling peptide P11-4 (Aggeli et al. 2001) for regenerating demineralized tooth tissue on smooth surfaces. This peptide forms a 3D matrix within demineralized carious lesions areas, which enables novo hydroxyapatite crystal formation facilitating the so-called guided enamel regeneration of the lost enamel structure (Deyhle et al. 2015; Kang et al. 2016) . The peptide has shown encouraging results as a scaffold for enamel regeneration. There is, however, still limited evidence of its use at the clinical level. The aim of this article is to present the current scientific evidence and clinical results for the self-assembling peptide P11-4 in a modern carious-lesion management concept.
Biomimetics with Self-Assembling Peptides
Fluorides are highly effective in caries prevention (Marinho et al. 2009) , and the global decline of caries is mostly attributed to their use (Bratthall et al. 1996) . In spite of possible caries arrest of even cavitated lesions by combining plaque removal and fluoride application (Lo et al. 1998) , the effect of fluorides is most pronounced in sound enamel and less pronounced in manifested carious lesions (Altenburger et al. 2010; Divaris et al. 2013 ). This is due to the high affinity of fluoride to hydroxyapatite. Mineralization or regeneration of the mineral within the subsurface lesion has been shown elusive with such treatments. This is because the enamel matrix proteins that control the enamel formation during odontogenesis are almost completely degraded during the final stage of maturation (Kirkham et al. 2000; Kirkham et al. 2002) . A regenerative approach with the substitution of the enamel matrix by a biomimetic matrix could enhance the remineralization of more advanced lesions. The self-assembling peptide P11-4 can form such a 3D matrix within the subsurface body of the initial enamel carious lesion and mimic enamel matrix proteins (Kirkham et al. 2007; Kind et al. 2017 ; Fig. 1 ). The P11-4 matrix has a high affinity for Ca 2+ ions and acts as a nucleator for de novo hydroxyapatite formation (Kirkham et al. 2007; Brunton et al. 2013; Kind et al. 2017; Sousa et al. 2017) .
Self-assembling peptide P11-4 has been clinically available as Curodont Repair. It undergoes hierarchical self-assembly to form tapes and ribbons within seconds, and fibrils and fibers within the following 24 h (Aggeli et al. 2001; Davies et al. 2006; Brunton et al. 2013 ; Fig. 1 ).
P11-4 was designed and screened for properties suitable for remineralization, such as a high affinity to hydroxyapatite and potential to nucleate hydroxyapatite (Kirkham et al. 2007 ). Its surface Ca 2+ -binding sites correspond exactly with the spacing of the columnar Ca 2+ ions in the hydroxyapatite crystal lattice (Brunton et al. 2013 ). Due to the fitting prepositioning of Ca 2+ ions, the activation energy of hydroxyapatite nucleation is reduced, and the remineralization with new hydroxyapatite crystals is enhanced (Fig. 2) .
Confocal microscopy and mass spectroscopy have shown that monomeric P11-4 diffuses through the pores of demineralized enamel, where fiber formation is triggered and the 3D matrix is formed (Kind et al. 2017 ; Fig. 3 ). C-labeled P11-4 indicated that ~35% of P11-4 remained within artificial carious lesions (Kind et al. 2017 ) being available for de novo hydroxyapatite crystal formation. Microtomography (microCT) analysis of remineralized specimens has shown remineralization of up to 90% of the original enamel density, with strong variation among specimens (Deyhle et al. 2015; Kang et al. 2016) .
The pH-cycling experiments of artificial carious lesions indicated that P11-4 clearly shifts the balance of de-and remineralization, resulting in a net increase in the mineral content (Kirkham et al. 2007 ). The minerals needed are provided by (artificial) saliva (Deyhle et al. 2015; Kang et al. 2016; Kind et al. 2017 ). This remineralization is mirrored by increased microhardness within the lesion body. Assessment of the changes in microhardness independent of the depth of the caries lesion has shown that P11-4 induced an increase in the microhardness down to 200 µm of the lesion. In contrast, control lesions treated with fluoride varnish exhibited a change in only the top 25 µm of the lesion, remaining unchanged in the subsurface body of the carious lesion (Schmidlin et al. 2016) . Takahashi et al. (2016) used ultrasonic velocity measurement to follow remineralization, and their results indicated increased mineral density after P11-4 treatment. This was also supported by the detection of newly formed nonprismatic hydroxyapatite crystals on the enamel surface in the subsequent scanning electron microscopy (SEM; Takahashi et al. 2016) , confirming previous X-ray diffraction (XRD) data by Kirkham et al. (2007) . Hydroxyapatite formation seems to be faster and yields larger crystals in the presence of P11-4 fibers than without them (Sousa et al. 2017) .
After establishing the mode of action of self-assembling peptide P11-4 in caries remineralization, its use in the treatment of carious lesions was monitored systematically. Artificial caries enamel lesions were divided in three groups and treated with self-assembling peptide P11-4 in artificial saliva, with self-assembling peptide P11-4 in distilled water, or with artificial saliva alone (Jablonski-Momeni and Heinzel-Gutenbrunner 2014). The assessment of the lesion with Diagnodent and VistaProof after 8 and 12 weeks showed almost complete remineralization for combined application of self-assembling peptide P11-4 and artificial saliva (Diagnodent, 8w: 24/30; 12w: 28/30; VistaProof, 8w: 27/28; 12 w: 27/27), whereas the two control groups presented significantly lower remineralization rates (Diagnodent, 8w: 1/10; 12w: 2/10; VistaProof, 8w: 5/8; 12w: 6/9).
Ex Vivo Studies
When investigating remineralization of natural carious lesions in human teeth, the mineral changes were monitored with the Canary System, which is based on measuring the reflection of light and heat from the enamel (Silvertown et al. 2017) . The three treatment groups consisted of untreated controls, a cleaning procedure (acid etching and wiping with sodium hypochloride) plus placebo solution, or full application of self-assembling peptide P11-4 (Curodont Repair) after the cleaning procedure. After storage in artificial saliva for 50 days, the baseline Canary Number of 40-50 (early carious lesions) remained basically unchanged for both control groups, but it reduced to values only slightly higher than that of sound enamel for the P11-4 group.
In contrast to the pH-cycling model, in which significant remineralization of artificial carious lesions was observed within 5 days (Kirkham et al. 2007 ), the remineralization of natural carious lesions occurred within 30 days, indicating longer remineralization for natural lesions. It is important to note that the sham treatment of etching and cleaning with sodium hypochlorite did not result in a change as measured by the Canary System. Thus, etching and sodium hypochlorite alone do not promote remineralization of enamel, which is also of relevance for the interpretation of the clinical studies.
Clinical Studies
Safety and clinical effects of self-assembling peptide P11-4 were first examined in an uncontrolled safety trial treating arrested carious lesions on buccal surfaces in 15 adults (Brunton et al. 2013) . Because no adverse events were recorded by the use of the product, and the blinded evaluation of the lesions showed a significant improvement of lesions as judged by size and perceived progression, further clinical studies were feasible.
In all clinical studies, self-assembling peptide P11-4 was applied as a monomeric solution formulated close to the transition pH to facilitate self-assembly within the carious lesion. In the study by Brunton et al. (2013) , a laboratory formulation was used, whereas in all other clinical studies, the formulation as in the product Curodont Repair was used. Prior to the application of the peptide, the enamel surface was cleaned chemically with sodium hypochlorite and etching gel (35% phosphoric acid).
In 25 patients with proximal carious lesions (Schlee et al. 2014; Schlee et al. 2017 ), the treatment effect of self-assembling peptide P11-4 was monitored with standardized radiographs that were evaluated by two independent blinded examiners and also by digital subtraction radiography (DSR) for baseline and the 1-year follow-up. The combined assessments indicated a clear trend toward regression of the lesions visible on clinical radiographs. Such radiographic lesion regression was previously reported and considered to be impossible by applying normal remineralization agents such as fluorides . The 6-month interim assessment yielded the following results: 31% of the carious lesions treated with P11-4 showed a strong mineralization, causing a class change into a lower caries stage according to ICDAS II (the International Caries Detection and Assessment System). Sixty-five percent of the lesions were assessed as unchanged in caries class, and one lesion progressed into the next ICDAS stage (Schlee et al. 2014) . The 1-year assessment, which was performed by two blinded assessors, included the DSR and yielded the following: 72% of the treated lesions showed overall regression, 14% remained unchanged, and 14% progressed (Schlee et al. 2017) . Because the lesions were proximal, it was not possible to assess their activity. Application to the lesion was performed by dropping the P11-4 solution into the proximal space. The tooth's hydrophilicity ensured retention of the P11-4 solution.
In a randomized, controlled, single-blinded study, the safety and clinical efficacy of P11-4 in treatment of initial caries were evaluated using a randomized controlled trial (RCT) design (Alkilzy et al. 2018) . The additional effect of the application of self-assembling peptide P11-4 (Curodont Repair) was compared to that of the application of fluoride varnish (Duraphat) alone. One-half of the 70 children (>5 years) with active occlusal initial caries lesions on erupting permanent molars was assigned to the test (n = 35, P11-4 + fluoride varnish), and the other half to the control group (n = 35, fluoride varnish only).
Lesions were assessed at baseline, and the products were applied in compliance with the manufacturer's instructions (Fig. 4) . Oral health instructions were given, and fluoride varnish was applied on both test and control lesions at baseline and follow-up sessions.
In the 3-and 6-month recalls, the test group showed, in both the laser fluorescence readings by Diagnodent and assessment of the caries activity according to the Nyvad criteria (Nyvad et al. 1999) , significantly superior lesion regression in the test group (odds ratio: 3.5, P = 0.015; 12.2, P < 0.0001, respectively). Clinically, more test lesions than control lesions showed regression in ICDAS scores (Fig. 5) .
No adverse events, medical complications, or allergic reactions related to the treatments were reported. Clinical applicability of test and control treatments was regarded as satisfactory, and was reported as easier than placing a filling or a sealant. All patients were willing to have future noninvasive treatments and to pay private treatment fees.
The results demonstrated that biomimetic mineralization facilitated by self-assembling peptide P11-4 in combination with fluoride is a simple, safe, and effective noninvasive treatment for early carious lesions, and is superior to the present clinical gold standard of fluoride treatment alone.
Perspectives
The remarkable caries decline of past decades, not just in children and adolescents but also in adults (Frencken et al. 2017) , was mostly attributed to the preventive effects of fluorides (Bratthall et al. 1996) . Fluorides, however, seem to be less effective in the arrest or remineralization of initial lesions (Altenburger et al. 2010; Schmidlin et al. 2016) , which leads to the development of alternative approaches such as sealing or infiltrating initial caries lesions (Splieth et al. 2010 ). In contrast to these composite-based treatment measures, biomimetic techniques, such as the self-assembling peptide P11-4, offer a therapeutic option for enamel regeneration. The self-assembling peptide P11-4 was designed to deliver a scaffold for improved (re)mineralization of the lesion body; this scaffold is thought to be in analogy to the formation of enamel. Several ex vivo studies proved the retention of P11-4 in enamel, plus the formation of de novo minerals and additional mineral deposits compared to the gold standard of fluorides. In addition, a clinical study confirmed this clearly for initial caries lesions in fissures of erupting permanent molars (Alkilzy et al. 2018 ). Thus, a promising future therapy to enhance remineralization of carious enamel has been systematically developed that should be investigated in further clinical settings, especially because detrimental side effects were not found.
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